Approval · Notice of Compliance 2275 · 2001
IDARAC: Notice of Compliance 2275
Issued April 2, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2275
- Date
- April 2, 2001
- Company
- Sanofi-Synthelabo Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anti-inflammatory, analgesic
Products in this notice
Medicinal ingredients
- FLOCTAFENINE 200 MG per TAB
- FLOCTAFENINE 400 MG per TAB